Lupus Nephritis Treatment: Moving Toward Targeted Biologics The treatment landscape for Lupus nephritis treatment is undergoing a significant transformation as targeted biologic therapies gain greater importance in managing autoimmune kidney disease. Among the therapies attracting considerable attention are BENLYSTA (belimumab) and GAZYVA (obinutuzumab). Although both address abnormal B-cell...